Heimdall Bio
PrivateLast Round
Seed
May 27, 2024
Company Overview
Heimdall Bio is a biotechnology company that develops AI-driven evaluation environments and metagenomics intelligence platforms for biodefense, biomolecular design, and synthetic biology research.
Sector
AI, Data & Cloud Infrastructure
Verticals
Biotechnology, AI Training Infrastructure, Drug Discovery, Synthetic Data, Defense Tech
Business Model
B2B
Customer Profile
Data as a Service, Subscription SaaS, Services & Consulting
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Heimdall Bio Comparables
Compare Heimdall Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Valthos | 63% | |
| OpenProtein.AI | 61% | |
| Edison Scientific | 61% | |
Heimdall Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | May 27, 2024 |
Heimdall Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Audere Capital | Seed |
Heimdall Bio Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Heimdall Bio's valuation, stock price, and market status.